Direct-to-consumer television advertising exposure, diagnosis with high cholesterol, and statin use

Journal of General Internal Medicine

Volumn 28, Issue 7, 2013, Pages 886-893

  Niederdeppe, Jeff ^a   Byrne, Sahara ^a   Avery, Rosemary J ^a   Cantor, Jonathan ^b  

^a Department of Obstetrics Gynecology   (United States)

^b NEW YORK UNIVERSITY   (United States)

Author keywords

cholesterol; direct to consumer advertising; DTCA; screening; statins; treatment

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ADVERTIZING; AGED; ARTICLE; CONSUMER; DRUG EXPOSURE; FEMALE; HIGH RISK POPULATION; HUMAN; HYPERCHOLESTEROLEMIA; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; TELEVISION; UNITED STATES;

ADOLESCENT; ADULT; ADVERTISING AS TOPIC; AGED; CONSUMER PARTICIPATION; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; TELEVISION; UNITED STATES; YOUNG ADULT;

EID: 84879552887     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-013-2379-3     Document Type: Article

References (31)

1. Miniño AM, Murphy SL, Xu J, Kochanek KD. Deaths: final Data for 2008. National Vital Statistics Reports; vol 59 no 10. Hyattsville, MD: National Center for Health Statistics; 2011.
2. National Heart, Lung and Blood Institute (NHLBI). High Blood Cholesterol: what You Need to Know. NIH Publication 05-3290. Washington, DC: US Department of Health and Human Services. Available at: http://www.nhlbi.nih.gov/health/ public/heart/chol/wyntk.htm. Last accessed January 16, 2013.
3. US Preventive Services Task Force (USPSTF). Screening for Lipid Disorders in Adults: Recommendation Statement. Rockville, MD: US Preventive Services Task Force. Available at: http://www.uspreventiveservicestaskforce.org/uspstf08/ lipid/lipidrs.htm. Last accessed January 16, 2013.
4. Blaha MJ, Nasir K, Blumenthal RS. Statin therapy for healthy men identified as:"increased risk". JAMA. 2012;307(14):1489-90.
5. Redberg RF, Katz MH. Healthy men should not take statins. JAMA. 2012;307(14):1491-2.
6. National Cholesterol Education Program (NCEP). Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (adult treatment panel III). Washington, DC: US Department of Health and Human Services. Available at: US Department of Health and Human Services. Available at: http://www.nhlbi.nih.gov/guidelines/cholesterol/index.htm. Last accessed January 16, 2013.
7. Donohue J. A history of drug advertising: the evolving roles of consumers and consumer protection. Milbank Q. 2006;84(4):659-99.
8. Donohue JM, Cevasco M, Rosenthal MB. A decade of direct-to-consumer advertising of prescription drugs. N Engl J Med. 2007;357(7):673-81.
9. Holmer AF. Direct-to-consumer advertising - strengthening our health care system. N Engl J Med. 2002;346(7):526-8.
10. Liu Q, Gupta S. the impact of direct-to-consumer advertising of prescription drugs on physician visits and drug requests: Empirical findings and public policy implications. Int J Res Market. 2011;28:205-17.
11. Frosch D, Grande D, Tarn DM, Kravitz RL. A decade of controversy: balancing policy with evidence in the regulation of prescription drug advertising. Am J Pub Health. 2010;100(1):1-32.
12. Macias W, Pashupati K, Lewis LS. A wonderful life or diarrhea and dry mouth? Policy issues of direct-to-consumer drug advertising on television. Health Comm. 2007;22(3):241-52.
13. Woloshin S, Schwartz LM, Tremmel J, Welch HG. Direct-to-consumer advertisements for prescription drugs: what are Americans being sold? Lancet. 2001;358(9288):1141-6.
14. Robinson AR, Hohmann KB, Rifkin JI, et al. Direct-to-consumer pharmaceutical advertising: physician and public opinion and potential effects on the physician-patient relationship. Arch Intern Med. 2004;16(4):427-32.
15. Weissman JS, Blumenthal D, Silk AJ, Zapert K, Newman M, Leitman R. Consumers' reports on the health effects of direct-to-consumer drug advertising. Health Aff (Milwood). 2003;W3(Suppl Web Exclusives):82-95.
16. Rosenthal M, Berndt E, Donohue J, et al. In: Cutler DM, Garber AM, eds. Demand Effects of Recent Changes in Prescription Drug Promotion. Frontiers in Health Policy Research, vol. 6. Cambridge: MIT Press; 2003.
17. Donohue J, Berndt E. Effects of direct-to-consumer advertising on medication choice: the case of antidepressants. J Pub Policy Mark. 2004;23(2):115-27.
18. Iizuka T, Jin GZ. The effects of prescription drug advertising on doctor visits. J Econ Manag Strat. 2005;14(3):701-27.
19. Block A. Cost and benefits of direct-to-consumer advertising: the case of depression. Pharmaeconomics. 2007;25(6):511-21.
20. Wonsinska M. Direct-to-consumer advertising and the demand for pharmaceutical products. J Mark Res. 2005;42(3):323-32.
21. Avery RJ, Kenkel D, et al. Public profits and public health: does advertising smoking cessation products encourage smokers to quit? J Polit Econ. 2007;115(3):447-81.
22. Avery RJ, Eisenberg M, Simon KI. The impact of direct-to-consumer television and magazine advertising on antidepressant use. Health Econ. In press.
23. Parnes B, Smith PC, et al. Lack of impact of direct-to-consumer advertising on the physician-patient encounter in primary care: aSNOCAP report. Ann Fam Med. 2009;7(1):41-6.
24. Spence MM, Teleki SS, et al. Direct-to-consumer advertising of Cox 2 inhibitors: effects on appropriateness of prescribing. Med Care Res Rev. 2005;62:544-59.
25. Kravitz RL, Epstein RM, et al. Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial. JAMA. 2005;293(16):1995-2002.
26. Gilbody S, Wilson P, Watt I. Benefits and harms of direct to consumer advertising: a systematic review. Qual Saf Health Care. 2005;14:246-50.
27. Mintzes B. Advertising of prescription-only medicines to the public: does evidence of benefit counterbalance harm? Annu Rev Pub Health. 2012;33:259-77.
28. Simmons National Consumer Survey. Available at: http://www.experian.com/ simmons-research/consumer-study.html. Last accessed January 16, 2013.
29. Kantar Media. Available at: http://kantarmediana.com/intelligence. Last accessed Jaunary 16, 2013.
30. US Centers for Disease Control and Prevention (CDC). Cholesterol: facts. Atlanta, GA: US Centers for Disease Control and Prevention. Available at: http://www.cdc.gov/cholesterol/facts.htm. Last accessed January 16, 2013.
31. Stagnitti MN. Statin Use Among Persons 18 and Older in the U S: Civilian Non-Institutionalized Population Reported as Receiving Medical Care For The Treatment Of High Cholesterol, 2002. Statistical Brief #95. Rockville, MD: Agency for Healthcare Research and Quality. 2005. Available at: http://meps.ahrq.gov/mepsweb/data-files/publications/st95/stat95.pdf. Last accessed January 16, 2013.